
|Articles|October 1, 2017
- Pharmaceutical Executive-10-01-2017
- Volume 37
- Issue 10
Pharmaceutical Executive, October 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive October 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 8 years ago
Pharm Exec's Emerging Pharma Leaders 2017over 8 years ago
How Pharmas, Payers, and Providers Can Meet the ‘Triple Aim’over 8 years ago
Glimmers of Hope for Innovation Support in Europeover 8 years ago
The Future of Real-World Studiesalmost 9 years ago
Inspiring People, Inspiring Teamsalmost 9 years ago
Country Report: ColombiaAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Novartis to Acquire Myricx Bio for $1.1 Billion
2
Reshoring Pharma and Biotech Manufacturing Ahead of This Summer’s Tariff Deadlines: Q&A with Ryan Last
3
How Regulatory Stringency, Demand Shocks, and Repurposing Reshape Biopharma Strategy in 2026
4
Traditional Healthcare Has a Retention Problem It Refuses to Diagnose
5




